• Login
    View Item 
    •   Athenaeum Home
    • University of Georgia Theses and Dissertations
    • University of Georgia Theses and Dissertations
    • View Item
    •   Athenaeum Home
    • University of Georgia Theses and Dissertations
    • University of Georgia Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Analysis of the risk and benefit information presented in broadcast direct-to-consumer advertising

    Thumbnail
    Date
    2009-08
    Author
    Thorsen, Arthur Sigird
    Metadata
    Show full item record
    Abstract
    The Food and Drug Administration (FDA) mandates that prescription drug advertisements cannot be false or misleading in any particular, must reveal material facts about the product being promoted, including facts about the consequences that can result from use of the product as suggested in the promotional piece and should present information about effectiveness and information about risk in a balanced manner.4,11 This study evaluates the a sampling of the current broadcast Direct-to-Consumer Advertising with the newly released FDA guidance document titled Presenting Risk Information in Prescription Drug and Medical Device Promotion. DRAFT GUIDANCE May 2009. The fair balance presentation of risk and benefit information within a cross section of drug advertisements was examined during two national nightly network television news broadcasts from May 25, 2009 to June 25, 2009.
    URI
    http://purl.galileo.usg.edu/uga_etd/thorsen_arthur_s_200908_ms
    http://hdl.handle.net/10724/25965
    Collections
    • University of Georgia Theses and Dissertations

    About Athenaeum | Contact Us | Send Feedback
     

     

    Browse

    All of AthenaeumCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    About Athenaeum | Contact Us | Send Feedback